Cargando…

Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening

Human protein kinase CK2 has emerged as promising target for the treatment of neoplastic diseases. The vast majority of kinase inhibitors known today target the ATP binding site, which is highly conserved among kinases and hence leads to limited selectivity. In order to identify non-ATP competitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nienberg, Christian, Garmann, Claudia, Gratz, Andreas, Bollacke, Andre, Götz, Claudia, Jose, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374410/ https://www.ncbi.nlm.nih.gov/pubmed/28067769 http://dx.doi.org/10.3390/ph10010006

Ejemplares similares

Functional display of heterotetrameric human protein kinase CK2 on Escherichia coli: a novel tool for drug discovery
por: Gratz, Andreas, et al.
Publicado: (2015)

A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors
por: Schnitzler, Alexander, et al.
Publicado: (2018)

Site-Specific Labeling of Protein Kinase CK2: Combining Surface Display and Click Chemistry for Drug Discovery Applications †
por: Nienberg, Christian, et al.
Publicado: (2016)

Protein kinase CK2 and ion channels (Review)
por: Montenarh, Mathias, et al.
Publicado: (2020)

Protein Kinase CK2 and Epstein–Barr Virus
por: Montenarh, Mathias, et al.
Publicado: (2023)

Antitumoral activity of allosteric inhibitors of protein kinase CK2
por: Moucadel, Virginie, et al.
Publicado: (2011)

Synthesis and SAR of Tetracyclic Inhibitors of Protein Kinase CK2 Derived from Furocarbazole W16
por: Kröger, Lukas, et al.
Publicado: (2020)

The protein kinase CK1: Inhibition, activation, and possible allosteric modulation
por: Sunkari, Yashoda Krishna, et al.
Publicado: (2022)

The Phosphorylation of PDX-1 by Protein Kinase CK2 Is Crucial for Its Stability
por: Klein, Sabrina, et al.
Publicado: (2016)

Protein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
por: Ampofo, Emmanuel, et al.
Publicado: (2019)

In Vitro and In Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2
por: Haidar, Samer, et al.
Publicado: (2019)

Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2
por: Alchab, Faten, et al.
Publicado: (2015)

Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7
por: Nacereddine, Abdelhamid, et al.
Publicado: (2018)

Natural Compounds Isolated from Stachybotrys chartarum Are Potent Inhibitors of Human Protein Kinase CK2
por: Haidar, Samer, et al.
Publicado: (2021)

Structures of pyruvate kinases display evolutionarily divergent allosteric strategies
por: Morgan, Hugh P., et al.
Publicado: (2014)

Impact of protein kinase CK2 inhibitors on proliferation and differentiation of neural stem cells
por: Bender, Melanie, et al.
Publicado: (2017)

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments
por: Moghaddam-Taaheri, Parisa, et al.
Publicado: (2016)

Control of TRPM3 Ion Channels by Protein Kinase CK2-Mediated Phosphorylation in Pancreatic β-Cells of the Line INS-1
por: Becker, Alexander, et al.
Publicado: (2021)

Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1
por: Kubiński, Konrad, et al.
Publicado: (2016)

Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α′
por: Hochscherf, Jennifer, et al.
Publicado: (2017)

Protein Kinase CK2 Contributes to Glucose Homeostasis by Targeting Fructose-1,6-Bisphosphatase 1
por: Pack, Mandy, et al.
Publicado: (2022)

An improved yeast surface display platform for the screening of nanobody immune libraries
por: Uchański, Tomasz, et al.
Publicado: (2019)

Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening
por: Li, Chunqiong, et al.
Publicado: (2020)

Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design
por: Chen, Xiaolan, et al.
Publicado: (2020)

Protein Kinase CK2 Controls Ca(V)2.1-Dependent Calcium Currents and Insulin Release in Pancreatic β-cells
por: Scheuer, Rebecca, et al.
Publicado: (2020)

Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase
por: Battisti, Umberto Maria, et al.
Publicado: (2023)

Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library
por: Hung, Ming-Szu, et al.
Publicado: (2009)

Protein Kinase CK2 Regulates Nerve/Glial Antigen (NG)2-Mediated Angiogenic Activity of Human Pericytes
por: Schmitt, Beate M., et al.
Publicado: (2020)

Functional interplay between the transcription factors USF1 and PDX-1 and protein kinase CK2 in pancreatic β-cells
por: Spohrer, Sarah, et al.
Publicado: (2017)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

Baculovirus Superinfection: A Probable Restriction Factor on the Surface Display of Proteins for Library Screening
por: Xu, Xiaodong, et al.
Publicado: (2013)

Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries
por: Huang, Aric, et al.
Publicado: (2022)

SGC-CK2-1 Is an Efficient Inducer of Insulin Production and Secretion in Pancreatic β-Cells
por: Pack, Mandy, et al.
Publicado: (2021)

A Novel Quantitative Kinase Assay Using Bacterial Surface Display and Flow Cytometry
por: Henriques, Sónia Troeira, et al.
Publicado: (2013)

The Glycine Receptor Allosteric Ligands Library (GRALL)
por: Cerdan, Adrien H, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
por: Nava, Maria G., et al.
Publicado: (2022)

Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK
por: Halekotte, Jakob, et al.
Publicado: (2017)

Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2
por: Liu, Shu, et al.
Publicado: (2013)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r72vhp47eopc8na6aoa3ul0ass